662.50
-7.50
(-1.12%)
As of 10:36:19 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
8,817,900
8,817,900
4,240,100
7,585,700
7,365,900
Investing Cash Flow
-9,301,500
-9,301,500
-7,152,700
-3,762,900
-2,867,500
Financing Cash Flow
1,230,100
1,230,100
3,495,600
-5,406,700
-4,131,300
End Cash Position
3,268,400
3,268,400
2,818,600
2,067,000
3,818,500
Capital Expenditure
-8,403,600
-8,403,600
-7,392,100
-2,985,300
-1,978,400
Issuance of Debt
11,417,100
11,417,100
3,958,500
--
2,410,800
Repayment of Debt
-664,200
-664,200
--
-1,560,000
-1,905,400
Repurchase of Capital Stock
-2,500,000
-2,500,000
-750,000
-1,500,000
-1,250,000
Free Cash Flow
414,300
414,300
-3,152,000
4,600,400
5,387,500
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMG.F Amgen Inc.
259.90
-0.76%
NOV.F Novo Nordisk A/S
56.41
-2.07%
NOTA.DU Novartis AG
96.60
-0.41%
BRM.F Bristol-Myers Squibb Company
43.80
-1.12%
NNO2.VI Novo Nordisk A/S
56.77
-3.37%
JNJ.F Johnson & Johnson
134.84
-1.07%
6MK.MU Merck & Co Inc
68.40
-1.72%
BRM.MU Bristol-Myers Squibb Co
43.77
-2.74%
NOVA.BE Novo Nordisk A/S
55.80
-2.11%
MRK.MX Merck & Co., Inc.
1,605.00
+0.53%